Cargando…

Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment

BACKGROUND: Toll-like receptor (TLR) agonists have important properties that can be exploited for immunotherapy against tumors. Locally injected immunostimulatory oligodeoxynucleotides containing CpG motifs (CpG-ODNs), which are TLR9 agonists, have shown promise in cancer models. Several studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben Abdelwahed, Rym, Cosette, Jérémie, Donnou, Sabrina, Crozet, Lucile, Ouakrim, Hanane, Fridman, Wolf Herman, Sautès-Fridman, Catherine, Mahjoub, Aouni, Fisson, Sylvain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623776/ https://www.ncbi.nlm.nih.gov/pubmed/23561041 http://dx.doi.org/10.1186/1756-9966-32-18

Ejemplares similares

Th17 Cells Are Involved in the Local Control of Tumor Progression in Primary Intraocular Lymphoma
por: Galand, Claire, et al.
Publicado: (2011)

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
por: Cosette, Jeremie, et al.
Publicado: (2016)

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models
por: Galand, Claire, et al.
Publicado: (2012)

Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis
por: Fisson, Sylvain, et al.
Publicado: (2013)

Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies
por: Donnou, Sabrina, et al.
Publicado: (2012)

Lung Tumor Microenvironment Induces Specific Gene Expression Signature in Intratumoral NK Cells
por: Gillard-Bocquet, Mélanie, et al.
Publicado: (2013)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020)

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine
por: Petitprez, Florent, et al.
Publicado: (2018)

Characteristics of tertiary lymphoid structures in primary cancers
por: Goc, Jérémy, et al.
Publicado: (2013)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

The European Academy of Tumor Immunology: Bridging fields, continents and generations
por: Kroemer, Guido, et al.
Publicado: (2012)

Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serum
por: Yagi, Hirokazu, et al.
Publicado: (2018)

Tumor Immunology, toward a Success Story?
por: Sautès-Fridman, Catherine
Publicado: (2015)

Intergenic, gene terminal, and intragenic CpG islands in the human genome
por: Medvedeva, Yulia A, et al.
Publicado: (2010)

Complement System: Promoter or Suppressor of Cancer Progression?
por: Revel, Margot, et al.
Publicado: (2020)

The immune microenvironment as a guide for cancer therapies
por: Fridman, Wolf H.
Publicado: (2012)

Metastatic Melanomas Express Inhibitory Low Affinity Fc Gamma Receptor and Escape Humoral Immunity
por: Cohen-Solal, Joel F. G., et al.
Publicado: (2010)

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
por: Sautès-Fridman, Catherine, et al.
Publicado: (2016)

B cells and cancer: To B or not to B?
por: Fridman, Wolf Herman, et al.
Publicado: (2020)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Mixing and CP violation in the B system
por: Fridman, A
Publicado: (1988)

Dilution measurements for CP violation in B decay
por: Fridman, A
Publicado: (1993)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012)

In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases
por: Arand, Julia, et al.
Publicado: (2012)

The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression
por: Petitprez, Florent, et al.
Publicado: (2020)

Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)

Editorial: Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer
por: Sautès-Fridman, Catherine, et al.
Publicado: (2022)

Remarks about CP violation measurements for B-mesons produced in pp interactions
por: Fridman, A
Publicado: (1990)

Integrating tumor microenvironment with cancer molecular classifications
por: Becht, Etienne, et al.
Publicado: (2015)

Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)

Comments on beauty baryon decays and CP-violation effects
por: Fridman, A, et al.
Publicado: (1993)

Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015)

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

Measurement possibilities of CP violation for B decays in pp collisions
por: Chaichian, Masud, et al.
Publicado: (1991)

On a possibility for measuring effects of CP violation at pp colliders
por: Chaichian, Masud, et al.
Publicado: (1993)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022)

The clinical role of the TME in solid cancer
por: Giraldo, Nicolas A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4ki36lo2fbk1e8gkek9b0irqj9